Photothermal ablation of cancer cells using folate-coated gold/graphene oxide composite

Risultato della ricerca: Article

12 Citazioni (Scopus)

Abstract

A new tumor targeted polymer-coated gold/graphene hybrid has been developed for achieving simultaneously thermoablation and chemoterapy of folate receptor-positive cancer cells.
Lingua originaleEnglish
pagine (da-a)433-443
Numero di pagine11
RivistaCURRENT DRUG DELIVERY
Volume14
Stato di pubblicazionePublished - 2017

Fingerprint

Graphite
Folic Acid
Gold
Oxides
Neoplasms
Polymers

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cita questo

@article{cbaa1030703042899369a8d83a364131,
title = "Photothermal ablation of cancer cells using folate-coated gold/graphene oxide composite",
abstract = "A new tumor targeted polymer-coated gold/graphene hybrid has been developed for achieving simultaneously thermoablation and chemoterapy of folate receptor-positive cancer cells.",
author = "Mariano Licciardi and Gaetano Giammona and Nicol{\`o} Mauro and Cinzia Scialabba and {Li Volsi}, Anna and Gennara Cavallaro and Mariano Licciardi and Gaetano Giammona",
year = "2017",
language = "English",
volume = "14",
pages = "433--443",
journal = "CURRENT DRUG DELIVERY",
issn = "1875-5704",

}

TY - JOUR

T1 - Photothermal ablation of cancer cells using folate-coated gold/graphene oxide composite

AU - Licciardi, Mariano

AU - Giammona, Gaetano

AU - Mauro, Nicolò

AU - Scialabba, Cinzia

AU - Li Volsi, Anna

AU - Cavallaro, Gennara

AU - Licciardi, Mariano

AU - Giammona, Gaetano

PY - 2017

Y1 - 2017

N2 - A new tumor targeted polymer-coated gold/graphene hybrid has been developed for achieving simultaneously thermoablation and chemoterapy of folate receptor-positive cancer cells.

AB - A new tumor targeted polymer-coated gold/graphene hybrid has been developed for achieving simultaneously thermoablation and chemoterapy of folate receptor-positive cancer cells.

UR - http://hdl.handle.net/10447/179079

M3 - Article

VL - 14

SP - 433

EP - 443

JO - CURRENT DRUG DELIVERY

JF - CURRENT DRUG DELIVERY

SN - 1875-5704

ER -